{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:13:39Z","timestamp":1779167619420,"version":"3.51.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Rhabdomyosarcoma is common in children and adolescents but rare in adults. Here, we presented a 41-year-old man with orbital-nasal alveolar rhabdomyosarcoma who underwent both <jats:sup>18<\/jats:sup>F-FDG and <jats:sup>18<\/jats:sup>FAl-NOTA-FAPI PET\/CT. <jats:sup>18<\/jats:sup>FAl-NOTA-FAPI PET\/CT showed intense uptake in the primary lesion and regional metastatic lymph nodes with an excellent tumor-to-background ratio, compared with the mild to moderate uptake on <jats:sup>18<\/jats:sup>F-FDG PET\/CT. In addition, <jats:sup>18<\/jats:sup>FAl-NOTA-FAPI PET\/CT detected bone metastases that were not identified by <jats:sup>18<\/jats:sup>F-FDG PET\/CT, which altered the patient\u2019s tumor stage and treatment strategy. This case suggests that <jats:sup>18<\/jats:sup>FAl-NOTA-FAPI PET\/CT maybe superior to <jats:sup>18<\/jats:sup>F-FDG PET\/CT in the assessment of adult orbital-nasal alveolar rhabdomyosarcoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005943","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T23:00:09Z","timestamp":1749596409000},"page":"793-794","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["18F-FAPI PET\/CT in An Adult Orbital-Nasal Alveolar Rhabdomyosarcoma: Comparisons With 18F-FDG PET\/CT"],"prefix":"10.1097","volume":"50","author":[{"given":"Hui","family":"Li","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingge","family":"Suo","sequence":"additional","affiliation":[{"name":"Ophthalmology, Peking University Third Hospital"},{"name":"Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jichao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Ophthalmology, Peking University Third Hospital"},{"name":"Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weifang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Ophthalmology, Peking University Third Hospital"},{"name":"Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Peking University Third Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"key":"R1-20250630","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/RLU.0b013e318217ae2e","article-title":"Additional benefit of F-18 FDG PET\/CT in the staging and follow-up of pediatric rhabdomyosarcoma","volume":"36","author":"Ricard","year":"2011","journal-title":"Clin Nucl Med"},{"key":"R2-20250630","doi-asserted-by":"crossref","first-page":"1047464","DOI":"10.3389\/fmed.2022.1047464","article-title":"Multimodality imaging evaluation of nasal sinus alveolar rhabdomyosarcoma: two case reports","volume":"9","author":"Huang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"R3-20250630","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1007\/s00259-022-05700-4","article-title":"Head-to-head evaluation of [(18)F]FDG and [(68) Ga]Ga-DOTA-FAPI-04 PET\/CT in recurrent soft tissue sarcoma","volume":"49","author":"Gu","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R4-20250630","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2967\/jnumed.121.262096","article-title":"(68)Ga-FAPI as a diagnostic tool in sarcoma: data from the (68)Ga-FAPI PET prospective observational trial","volume":"63","author":"Kessler","year":"2022","journal-title":"J Nucl Med"},{"key":"R5-20250630","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.semnuclmed.2024.01.001","article-title":"Fibroblast activation protein inhibitor (FAPI) PET imaging in sarcomas: a new frontier in nuclear medicine","volume":"54","author":"Giammarile","year":"2024","journal-title":"Semin Nucl Med"},{"key":"R6-20250630","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2967\/jnumed.123.267248","article-title":"(68)Ga-fibroblast activation protein inhibitor PET\/CT improves detection of intermediate and low-grade sarcomas and identifies candidates for radiopharmaceutical therapy","volume":"65","author":"Lanzafame","year":"2024","journal-title":"J Nucl Med"},{"key":"R7-20250630","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-015-0342-8","article-title":"Rhabdomyosarcoma in adults: new perspectives on therapy","volume":"16","author":"Ruiz-Mesa","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"R8-20250630","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1097\/PAS.0b013e3181be6209","article-title":"Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis","volume":"33","author":"Stock","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R9-20250630","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/diagnostics13183006","article-title":"Comparison of (18)F-FDG PET\/CT and (68)Ga-FAPI in spindle cell rhabdomyosarcoma","volume":"13","author":"Shen","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"R10-20250630","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4274\/mirt.galenos.2022.96977","article-title":"(11)C-Methionine PET\/CT and (18)F-FDG PET\/CT in the evaluation of adult alveolar rhabdomyosarcoma","volume":"32","author":"Hiroshima","year":"2023","journal-title":"Mol Imaging Radionucl Ther"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005943","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:01:19Z","timestamp":1751299279000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005943","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"2024-11-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}